Paid Osteoarthritis Clinical Trials
Osteoarthritis clinical trials now enrolling. Access new treatments for knee and hip OA. Compensation up to $2,800. Studies for chronic joint pain.
Compensation
$1,400 - $2,800
Duration
16-52 weeks
Phase
Phase II/III
FDA Regulated
IRB Approved
GCP Certified
Who May Qualify
- Age 40-80 years
- Diagnosis of knee or hip osteoarthritis (ACR criteria)
- Kellgren-Lawrence grade 2-4 on X-ray
- Moderate to severe pain despite analgesic use
- BMI ≤ 40 kg/m²
- Ambulatory without assistive devices (or minimal use)
Who May Not Qualify
- Inflammatory arthritis (rheumatoid, psoriatic, gout)
- Recent knee/hip injection (within 3 months)
- Planned joint replacement during study period
- Prior joint replacement in the study joint
- Significant joint malalignment
Frequently Asked Questions
What osteoarthritis treatments are being studied?
+
Studies include nerve growth factor inhibitors, injectable therapies (new biologics, gene therapies), disease-modifying OA drugs, and regenerative approaches like stem cells.
Will I need X-rays or MRI during the study?
+
X-rays are typically required at screening and may be repeated during the study. Some studies use MRI to assess cartilage and joint structure in more detail.
Can I continue taking pain medications?
+
Most studies allow acetaminophen as rescue medication but require washout of NSAIDs. The specific pain medication requirements vary by protocol.
Are there studies involving injections?
+
Yes, many OA studies involve intra-articular (joint) injections of investigational treatments. These are typically performed by experienced physicians with ultrasound guidance.